Developer docs
API playgroundTry for free, no card

Search company profiles

johnson & johnson vision

Full company profile

uuid02m3ge8

Namestring
johnson & johnson vision
Legal namestring
Johnson & Johnson Vision Care, Inc.
Websiteurl
acuvuepro.net
Company typeenum
Public
Founded yearint
1950
Descriptiontext

Johnson & Johnson Vision is the wholly-owned eye health business unit of Johnson & Johnson (NYSE: JNJ), operating within the J&J MedTech division from its headquarters in Jacksonville, Florida. The unit develops and commercializes a comprehensive portfolio spanning contact lenses (ACUVUE brand), surgical vision products (TECNIS intraocular lenses, CATALYS precision laser cataract system, iDESIGN refractive studio, iFS femtosecond laser, HEALON ophthalmic viscoelastic devices), and ocular surface diagnostics and treatment (LipiScan, LipiView II, LipiFlow thermal pulsation). The company serves two primary end-customers: eye care professionals (optometrists and ophthalmologists) who prescribe and dispense products, and the patients they treat for vision correction, cataract surgery, myopia management, and dry eye disease.

The business operates a B2B2C model with strong direct-to-ECP mechanics. Field sales representatives, a direct ordering portal, and the ACUVUE Preferred Program serve enrolled practices, while ACUVUE Checkout & Shop, Find an Eye Doctor, MyACUVUE Rewards (up to $200 back), and LensAssist provide patient-facing engagement. The unit is the most trusted contact lens brand among ECPs based on 47 clinical studies, with proprietary technologies including TearStable Technology, OptiBlue Light Filter (60% blue-violet filtering), BLINK STABILIZED Design, and PUPIL OPTIMIZED Design providing technical differentiation. Revenue is generated through hardware sales of contact lenses, surgical systems, IOLs, and ocular surface devices, supplemented by practice services programs.

The unit's strategic posture reflects portfolio consolidation around the daily disposable OASYS MAX 1-Day platform, premium IOL expansion via TECNIS PureSee, and targeted legacy product rationalization (discontinuations of 1-DAY ACUVUE TruEye, ACUVUE OASYS for Presbyopia, and ACUVUE OASYS with Transitions). The portfolio is supported by acquired capabilities from Abbott Medical Optics (2017) and the corneal health business (2009), and is positioned against a structural tailwind in myopia prevalence, which is projected to affect half the global population by 2050.

Short descriptiontext

Johnson & Johnson Vision is the wholly-owned eye health business unit of Johnson & Johnson (NYSE: JNJ) that develops and commercializes ACUVUE contact lenses, TECNIS intraocular lenses, cataract surgery systems, and ocular surface diagnostics and treatment products to eye care professionals and patients in the United States.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersJacksonville, United States
HQ citystring
Jacksonville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contact lenses, cataract surgery devices, intraocular lenses, ocular surface treatment, eye care products
Industry3 codes
1Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions)
CodeHLAHAJAEPrimaryYes
2Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics)
CodeHLAHAJAHPrimaryNo
3Contact Lens Specialty & Myopia Control
CodeHLAKAKAKPrimaryNo
NAICS code1 code
  • Ophthalmic Goods Manufacturing339115
SIC code2 codes
  • Ophthalmic Goods3851
  • Surgical & Medical Instruments & Apparatus3841
Product category
Ophthalmic Medical Devices and Contact Lenses
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Contact Lens Sales
TypeHardware Sales
Description

Sale of ACUVUE brand contact lenses to eye care practices and patients through direct ordering, ecommerce, and retail channels. Includes spherical, toric, and multifocal variants across daily disposable and two-week modalities.

jnjvisionpro.com
2Surgical Vision Products
TypeHardware Sales
Description

Sale of intraocular lenses (TECNIS portfolio), cataract surgery systems, LASIK technology, and associated surgical consumables to eye care practices and hospitals.

jnjvisionpro.com
3Ocular Surface Diagnostics and Treatment
TypeHardware Sales
Description

Sale of TearScience products including LipiScan, LipiView, and LipiFlow systems for MGD assessment and treatment.

jnjvisionpro.com
4Practice Services and Programs
TypeProfessional Services
Description

Preferred program services, practice support tools, and professional resources for eye care practices.

jnjvisionpro.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain, Infrastructure
Pricing details3 tiers
1Patient Rewards - MyACUVUE program
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Up to $200 back for patients through MyACUVUE rewards

jnjvisionpro.com
2Comfort Promise Guarantee
ModelOutcome Based/ PerformanceBilling cadencePay-as-you-go
Notes

100% comfort guarantee or money back on up to two opened boxes of contacts

jnjvisionpro.com
3Direct Ordering for Practices
ModelOtherBilling cadencePay-as-you-go
Notes

Exclusive access to promotions and preferred pricing for registered eye care practices. Free shipping on orders of $100 or more.

jnjvisionpro.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1ACUVUE
Description

Brand of contact lenses including OASYS MAX, MOIST, VITA, and DEFINE product lines for spherical, toric, and multifocal correction.

jnjvisionpro.com
+8 more records
Core offering1 text field

Johnson & Johnson Vision manufactures and sells ACUVUE® brand contact lenses (daily disposable, two-week, and monthly modalities for spherical, toric/astigmatism, and multifocal/presbyopia correction), surgical vision products including TECNIS® intraocular lenses and the CATALYS® precision laser cataract surgery system, and ocular surface diagnostics and treatment systems (LipiFlow®, LipiScan®, LipiView®) for meibomian gland dysfunction. Products are sold primarily through a field sales force and direct ordering portal to eye care professionals, with a parallel consumer ecommerce channel.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 99% first fit success rate for ACUVUE OASYS MAX 1-Day for Astigmatism
+4 more records
Product overview1 text field

Johnson & Johnson Vision offers a comprehensive portfolio of eye care products across three main categories: Contact Lenses (ACUVUE® brand), Surgical Vision (cataract surgery devices and IOLs), and Ocular Surface (dry eye diagnostics and treatment). The ACUVUE® contact lens portfolio includes daily disposable options (ACUVUE® OASYS MAX 1-Day family, 1-DAY ACUVUE® MOIST), two-week options (ACUVUE OASYS® 2-WEEK), and monthly options (ACUVUE® VITA®), serving spherical, toric (astigmatism), and multifocal (presbyopia) patients. The surgical vision portfolio includes the CATALYS® laser system, VERITAS™ and COMPACT INTUITIV phaco systems, TECNIS™ IOL family (including PureSee™ EDOF IOL, Eyhance™, multifocal, and toric options), and refractive surgery systems (iDESIGN®, iFS™, STAR S4 IR™). The TearScience™ MGD portfolio provides diagnostic (LipiScan™, LipiView II) and treatment (LipiFlow®) solutions for ocular surface disease. Practice support services include ACUVUE® Checkout & Shop e-commerce, LensAssist® patient training, MyACUVUE® Rewards, and the ACUVUE Preferred Program.

Product and service19 records
1ACUVUE® OASYS MAX 1-Day for ASTIGMATISM
CategoryContact Lenses - Daily Disposable Toric
Description

Daily disposable toric contact lens for astigmatism correction featuring TearStable™ Technology, OptiBlue™ Light Filter (60% blue-violet filtering), and Cylinder Optimized BLINK STABILIZED® Design. Delivers exceptional comfort, clarity, and stability for patients with astigmatism.

2ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM
CategoryContact Lenses - Daily Disposable Multifocal Toric
Description

First and only daily disposable multifocal toric contact lens. Delivers crisp, clear vision at all distances and lighting conditions with TearStable™ Technology, OptiBlue™ Light Filter, PUPIL OPTIMIZED Design, and BLINK STABILIZED® Design.

3ACUVUE® OASYS MAX 1-Day
CategoryContact Lenses - Daily Disposable Spherical
Description

Daily disposable spherical contact lens delivering all-day comfort and visual clarity with TearStable™ Technology and OptiBlue™ Light Filter.

4ACUVUE® OASYS MAX 1-Day MULTIFOCAL
CategoryContact Lenses - Daily Disposable Multifocal
Description

Daily disposable multifocal contact lens with PUPIL OPTIMIZED DESIGN for presbyopia correction, delivering clear vision near, far, and in between.

51-DAY ACUVUE® MOIST
CategoryContact Lenses - Daily Disposable
Description

Daily disposable contact lens with LACREON® technology for moisture retention and all-day comfort.

6ACUVUE OASYS® 1-Day with HydraLuxe® Technology
CategoryContact Lenses - Daily Disposable
Description

Daily disposable lens with HydraLuxe® Technology for enhanced tear-film stability and comfort.

7ACUVUE OASYS® 2-WEEK with HYDRACLEAR® PLUS
CategoryContact Lenses - Two-Week Reusable
Description

Two-week reusable contact lens with HYDRACLEAR® PLUS technology for sustained comfort.

8ACUVUE® VITA®
CategoryContact Lenses - Monthly
Description

Monthly replacement contact lens designed for reliable comfort throughout the month.

9ACUVUE® DEFINE™
CategoryContact Lenses - Daily Disposable Aesthetic
Description

Daily disposable aesthetic contact lens that enhances natural eye color while providing vision correction.

10TECNIS PureSee™ IOL
CategoryIntraocular Lenses - Cataract Surgery
Description

Purely refractive extended depth-of-focus (EDOF) intraocular lens with monofocal-like dysphotopsia profile. Provides improved intermediate visual acuity while maintaining comparable distance visual acuity for cataract surgery patients.

11TECNIS™ Eyhance™ IOL
CategoryIntraocular Lenses - Cataract Surgery
Description

Aspheric monofocal intraocular lens with enhanced intermediate vision performance.

12TECNIS™ Multifocal IOL +3.25D
CategoryIntraocular Lenses - Multifocal
Description

Multifocal intraocular lens with +3.25 diopter add power for near vision correction.

13TECNIS™ Multifocal Toric II IOL +3.25D
CategoryIntraocular Lenses - Multifocal Toric
Description

Multifocal toric intraocular lens combining astigmatism correction with +3.25D near addition.

14LipiFlow® Thermal Pulsation System
CategoryOcular Surface Treatment Device
Description

Thermal pulsation device for treatment of meibomian gland dysfunction (MGD) and dry eye disease.

15LipiScan™ Dynamic Meibomian Imager
CategoryOcular Surface Diagnostic Device
Description

Diagnostic imaging device for meibomian gland evaluation in dry eye assessment.

16LipiView II Ocular Surface Interferometer
CategoryOcular Surface Diagnostic Device
Description

Ocular surface interferometer for measuring tear film lipid layer and meibomian gland function.

17CATALYS® Precision Laser System
CategorySurgical Vision - Cataract Laser System
Description

Laser cataract surgery platform for precision corneal incisions and lens fragmentation.

18iDESIGN® Refractive Studio
CategoryRefractive Surgery Equipment
Description

Wavefront-guided refractive planning system for LASIK and other refractive procedures.

19iFS™ Advanced Femtosecond Laser
CategoryRefractive Surgery Equipment
Description

Femtosecond laser for corneal flap creation in LASIK procedures.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

Third-party accessibility experts engaged by Johnson & Johnson Vision to achieve and sustain conformance to WCAG accessibility standards. Provides decades of experience and technology for designing, developing, and testing websites and online services.

Strategic tierFoundationalTypeOthers
Description

Johnson & Johnson Vision supports the AdvaMed Code of Ethics on interacting with Healthcare Professionals. The company's California compliance program is informed by AdvaMed standards.

Strategic tierSupportingTypeOthers
Description

Eye health expertise referenced by ACUVUE for educational content development and clinical guidance.

Strategic tierSupportingTypeOthers
Description

Eye health expertise referenced by ACUVUE for educational content development and clinical guidance.

Strategic tierSupportingTypeOthers
Description

Government eye health authority referenced for educational content on vision, vision care, and vision correction information.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CooperVision is a leading global contact lens manufacturer (MyDay, clariti, Biofinity) and a direct competitor in soft contact lenses, particularly in toric and multifocal segments where J&J Vision competes with OASYS MAX 1-Day products.

TypeDirect peer
Description

Bausch + Lomb is a major direct competitor in contact lenses (Biotrue, Ultra, Infuse), ophthalmic surgical devices, and ocular health products. Competes head-to-head with ACUVUE in daily disposable and monthly replacement categories globally.

TypeDirect peer
Description

Carl Zeiss Meditec competes directly in the surgical vision space with intraocular lenses, ophthalmic surgical microscopes, and refractive laser systems (VisuMax, SMILE), overlapping with J&J Vision's TECNIS IOL, CATALYS, and iDESIGN/iFS surgical portfolio.

TypeDirect peer
Description

HOYA is a competitor in intraocular lenses (HOYA iSert, Vivinex IOL family) and ophthalmic surgical devices, directly competing with J&J Vision's TECNIS IOL portfolio in the cataract surgery market.

TypeBroad incumbent
Description

EssilorLuxottica is a global eyewear giant spanning frames, lenses (Transitions, Varilux), and retail (LensCrafters, Sunglass Hut). While primarily an eyeglass company rather than contact lens competitor, it competes indirectly for vision correction share and shares the same ECP distribution channel.

TypeDirect peer
Description

Alcon is the world's largest eye care company and J&J Vision's most direct competitor. Both offer comprehensive contact lens portfolios (Alcon: Dailies, Air Optix, Precision1 vs J&J: ACUVUE OASYS, MOIST) and surgical vision products (Alcon: PanOptix IOL, Centurion vs J&J: TECNIS, CATALYS), targeting the same ECP channel and patient base.

TypeOthers
Description

Heidelberg Engineering specializes in diagnostic imaging for ophthalmology (Spectralis OCT, HRT). While not directly competitive with J&J Vision's products, it serves the same ECP customer base with complementary diagnostic equipment.

TypeEmerging player
Description

Glaukos is an emerging player in ophthalmic medical devices focused on MIGS (micro-invasive glaucoma surgery) and dry eye treatment (iDose TR). Adjacent to J&J Vision's ocular surface portfolio (LipiFlow) and represents a competitor in newer ophthalmic treatment modalities.

TypeEmerging player
Description

Topcon Healthcare provides ophthalmic diagnostic equipment, imaging systems, and healthcare IT solutions. Overlaps with J&J Vision's LipiScan/LipiView ocular surface diagnostics and competes for ECP practice equipment budgets.

TypeDirect peer
Description

STAAR Surgical is a direct competitor in premium IOLs, particularly known for its EVO ICL (Implantable Collamer Lens) for refractive vision correction. Competes with J&J Vision's surgical vision portfolio in the premium refractive surgery market.

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

johnson & johnson vision

Ophthalmic Medical Devices and Contact Lensesacuvuepro.net

Johnson & Johnson Vision is the wholly-owned eye health business unit of Johnson & Johnson (NYSE: JNJ) that develops and commercializes ACUVUE contact lenses, TECNIS intraocular lenses, cataract surgery systems, and ocular surface diagnostics and treatment products to eye care professionals and patients in the United States.

What johnson & johnson vision does

Johnson & Johnson Vision is the wholly-owned eye health business unit of Johnson & Johnson (NYSE: JNJ), operating within the J&J MedTech division from its headquarters in Jacksonville, Florida. The unit develops and commercializes a comprehensive portfolio spanning contact lenses (ACUVUE brand), surgical vision products (TECNIS intraocular lenses, CATALYS precision laser cataract system, iDESIGN refractive studio, iFS femtosecond laser, HEALON ophthalmic viscoelastic devices), and ocular surface diagnostics and treatment (LipiScan, LipiView II, LipiFlow thermal pulsation). The company serves two primary end-customers: eye care professionals (optometrists and ophthalmologists) who prescribe and dispense products, and the patients they treat for vision correction, cataract surgery, myopia management, and dry eye disease.

The business operates a B2B2C model with strong direct-to-ECP mechanics. Field sales representatives, a direct ordering portal, and the ACUVUE Preferred Program serve enrolled practices, while ACUVUE Checkout & Shop, Find an Eye Doctor, MyACUVUE Rewards (up to $200 back), and LensAssist provide patient-facing engagement. The unit is the most trusted contact lens brand among ECPs based on 47 clinical studies, with proprietary technologies including TearStable Technology, OptiBlue Light Filter (60% blue-violet filtering), BLINK STABILIZED Design, and PUPIL OPTIMIZED Design providing technical differentiation. Revenue is generated through hardware sales of contact lenses, surgical systems, IOLs, and ocular surface devices, supplemented by practice services programs.

The unit's strategic posture reflects portfolio consolidation around the daily disposable OASYS MAX 1-Day platform, premium IOL expansion via TECNIS PureSee, and targeted legacy product rationalization (discontinuations of 1-DAY ACUVUE TruEye, ACUVUE OASYS for Presbyopia, and ACUVUE OASYS with Transitions). The portfolio is supported by acquired capabilities from Abbott Medical Optics (2017) and the corneal health business (2009), and is positioned against a structural tailwind in myopia prevalence, which is projected to affect half the global population by 2050.

johnson & johnson vision firmographics

Firmographics
Name
johnson & johnson vision
Legal name
Johnson & Johnson Vision Care, Inc.
Website
https://acuvuepro.net
Company type
Public
Founded year
1950
Operating status
Operating
Short description
Johnson & Johnson Vision is the wholly-owned eye health business unit of Johnson & Johnson (NYSE: JNJ) that develops and commercializes ACUVUE contact lenses, TECNIS intraocular lenses, cataract surgery systems, and ocular surface diagnostics and treatment products to eye care professionals and patients in the United States.
Ownership category
akta.pro rank

johnson & johnson vision industry classification

Industry
Product category
Ophthalmic Medical Devices and Contact Lenses
NAICS
Ophthalmic Goods Manufacturing (339115)
SIC
Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)
akta.pro secondary industries
Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Contact Lens Specialty & Myopia Control (HLAKAKAK)

Keywords

  • Contact lenses
  • Cataract surgery devices
  • Intraocular lenses
  • Ocular surface treatment
  • Eye care products

Where johnson & johnson vision is headquartered

Location

Headquarters

HQ city
Jacksonville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

johnson & johnson vision business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain, Infrastructure

Revenue model

  1. Contact Lens Sales: Sale of ACUVUE brand contact lenses to eye care practices and patients through direct ordering, ecommerce, and retail channels. Includes spherical, toric, and multifocal variants across daily disposable and two-week modalities.
  2. Surgical Vision Products: Sale of intraocular lenses (TECNIS portfolio), cataract surgery systems, LASIK technology, and associated surgical consumables to eye care practices and hospitals.
  3. Ocular Surface Diagnostics and Treatment: Sale of TearScience products including LipiScan, LipiView, and LipiFlow systems for MGD assessment and treatment.
  4. Practice Services and Programs: Preferred program services, practice support tools, and professional resources for eye care practices.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goPatient Rewards - MyACUVUE program
Outcome Based/ PerformancePay-as-you-goComfort Promise Guarantee
OtherPay-as-you-goDirect Ordering for Practices

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

johnson & johnson vision product offering

Product offering

Core offering

Johnson & Johnson Vision manufactures and sells ACUVUE® brand contact lenses (daily disposable, two-week, and monthly modalities for spherical, toric/astigmatism, and multifocal/presbyopia correction), surgical vision products including TECNIS® intraocular lenses and the CATALYS® precision laser cataract surgery system, and ocular surface diagnostics and treatment systems (LipiFlow®, LipiScan®, LipiView®) for meibomian gland dysfunction. Products are sold primarily through a field sales force and direct ordering portal to eye care professionals, with a parallel consumer ecommerce channel.

Product overview

Johnson & Johnson Vision offers a comprehensive portfolio of eye care products across three main categories: Contact Lenses (ACUVUE® brand), Surgical Vision (cataract surgery devices and IOLs), and Ocular Surface (dry eye diagnostics and treatment). The ACUVUE® contact lens portfolio includes daily disposable options (ACUVUE® OASYS MAX 1-Day family, 1-DAY ACUVUE® MOIST), two-week options (ACUVUE OASYS® 2-WEEK), and monthly options (ACUVUE® VITA®), serving spherical, toric (astigmatism), and multifocal (presbyopia) patients. The surgical vision portfolio includes the CATALYS® laser system, VERITAS™ and COMPACT INTUITIV phaco systems, TECNIS™ IOL family (including PureSee™ EDOF IOL, Eyhance™, multifocal, and toric options), and refractive surgery systems (iDESIGN®, iFS™, STAR S4 IR™). The TearScience™ MGD portfolio provides diagnostic (LipiScan™, LipiView II) and treatment (LipiFlow®) solutions for ocular surface disease. Practice support services include ACUVUE® Checkout & Shop e-commerce, LensAssist® patient training, MyACUVUE® Rewards, and the ACUVUE Preferred Program.

Differentiator

Problem solved

Functional benefit

Brands

  • ACUVUE: Brand of contact lenses including OASYS MAX, MOIST, VITA, and DEFINE product lines for spherical, toric, and multifocal correction.
  • TECNIS
  • TECNIS PureSee
  • LipiScan
  • LipiFlow
  • CATALYS
  • HEALON
  • iDESIGN
  • ABILITI

Products and services

  • ACUVUE® OASYS MAX 1-Day for ASTIGMATISM Daily disposable toric contact lens for astigmatism correction featuring TearStable™ Technology, OptiBlue™ Light Filter (60% blue-violet filtering), and Cylinder Optimized BLINK STABILIZED® Design. Delivers exceptional comfort, clarity, and stability for patients with astigmatism.
  • ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM First and only daily disposable multifocal toric contact lens. Delivers crisp, clear vision at all distances and lighting conditions with TearStable™ Technology, OptiBlue™ Light Filter, PUPIL OPTIMIZED Design, and BLINK STABILIZED® Design.
  • ACUVUE® OASYS MAX 1-Day Daily disposable spherical contact lens delivering all-day comfort and visual clarity with TearStable™ Technology and OptiBlue™ Light Filter.
  • ACUVUE® OASYS MAX 1-Day MULTIFOCAL Daily disposable multifocal contact lens with PUPIL OPTIMIZED DESIGN for presbyopia correction, delivering clear vision near, far, and in between.
  • 1-DAY ACUVUE® MOIST Daily disposable contact lens with LACREON® technology for moisture retention and all-day comfort.
  • ACUVUE OASYS® 1-Day with HydraLuxe® Technology Daily disposable lens with HydraLuxe® Technology for enhanced tear-film stability and comfort.
  • ACUVUE OASYS® 2-WEEK with HYDRACLEAR® PLUS Two-week reusable contact lens with HYDRACLEAR® PLUS technology for sustained comfort.
  • ACUVUE® VITA® Monthly replacement contact lens designed for reliable comfort throughout the month.
  • ACUVUE® DEFINE™ Daily disposable aesthetic contact lens that enhances natural eye color while providing vision correction.
  • TECNIS PureSee™ IOL Purely refractive extended depth-of-focus (EDOF) intraocular lens with monofocal-like dysphotopsia profile. Provides improved intermediate visual acuity while maintaining comparable distance visual acuity for cataract surgery patients.
  • TECNIS™ Eyhance™ IOL Aspheric monofocal intraocular lens with enhanced intermediate vision performance.
  • TECNIS™ Multifocal IOL +3.25D Multifocal intraocular lens with +3.25 diopter add power for near vision correction.
  • TECNIS™ Multifocal Toric II IOL +3.25D Multifocal toric intraocular lens combining astigmatism correction with +3.25D near addition.
  • LipiFlow® Thermal Pulsation System Thermal pulsation device for treatment of meibomian gland dysfunction (MGD) and dry eye disease.
  • LipiScan™ Dynamic Meibomian Imager Diagnostic imaging device for meibomian gland evaluation in dry eye assessment.
  • LipiView II Ocular Surface Interferometer Ocular surface interferometer for measuring tear film lipid layer and meibomian gland function.
  • CATALYS® Precision Laser System Laser cataract surgery platform for precision corneal incisions and lens fragmentation.
  • iDESIGN® Refractive Studio Wavefront-guided refractive planning system for LASIK and other refractive procedures.
  • iFS™ Advanced Femtosecond Laser Femtosecond laser for corneal flap creation in LASIK procedures.

Quantifiable outcome

  • 99% first fit success rate for ACUVUE OASYS MAX 1-Day for Astigmatism
  • +4 more outcomes

Companies that use johnson & johnson vision

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

johnson & johnson vision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

johnson & johnson vision partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered supporting and foundational.

  • Level AccesssupportingImplementation/ SI/ Consulting PartnerThird-party accessibility experts engaged by Johnson & Johnson Vision to achieve and sustain conformance to WCAG accessibility standards. Provides decades of experience and technology for designing, developing, and testing websites and online services.
  • AdvaMed (Advanced Medical Technology Association)foundationalOthersJohnson & Johnson Vision supports the AdvaMed Code of Ethics on interacting with Healthcare Professionals. The company's California compliance program is informed by AdvaMed standards.
  • American Academy of OphthalmologysupportingOthersEye health expertise referenced by ACUVUE for educational content development and clinical guidance.
  • American Optometric AssociationsupportingOthersEye health expertise referenced by ACUVUE for educational content development and clinical guidance.
  • National Eye InstitutesupportingOthersGovernment eye health authority referenced for educational content on vision, vision care, and vision correction information.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

johnson & johnson vision competitors and assessment

Company assessment

Direct peers

  • CooperVision: CooperVision is a leading global contact lens manufacturer (MyDay, clariti, Biofinity) and a direct competitor in soft contact lenses, particularly in toric and multifocal segments where J&J Vision competes with OASYS MAX 1-Day products.
  • Bausch + Lomb: Bausch + Lomb is a major direct competitor in contact lenses (Biotrue, Ultra, Infuse), ophthalmic surgical devices, and ocular health products. Competes head-to-head with ACUVUE in daily disposable and monthly replacement categories globally.
  • Carl Zeiss Meditec: Carl Zeiss Meditec competes directly in the surgical vision space with intraocular lenses, ophthalmic surgical microscopes, and refractive laser systems (VisuMax, SMILE), overlapping with J&J Vision's TECNIS IOL, CATALYS, and iDESIGN/iFS surgical portfolio.
  • HOYA Corporation: HOYA is a competitor in intraocular lenses (HOYA iSert, Vivinex IOL family) and ophthalmic surgical devices, directly competing with J&J Vision's TECNIS IOL portfolio in the cataract surgery market.
  • Alcon: Alcon is the world's largest eye care company and J&J Vision's most direct competitor. Both offer comprehensive contact lens portfolios (Alcon: Dailies, Air Optix, Precision1 vs J&J: ACUVUE OASYS, MOIST) and surgical vision products (Alcon: PanOptix IOL, Centurion vs J&J: TECNIS, CATALYS), targeting the same ECP channel and patient base.
  • STAAR Surgical: STAAR Surgical is a direct competitor in premium IOLs, particularly known for its EVO ICL (Implantable Collamer Lens) for refractive vision correction. Competes with J&J Vision's surgical vision portfolio in the premium refractive surgery market.

Broad incumbents

  • EssilorLuxottica: EssilorLuxottica is a global eyewear giant spanning frames, lenses (Transitions, Varilux), and retail (LensCrafters, Sunglass Hut). While primarily an eyeglass company rather than contact lens competitor, it competes indirectly for vision correction share and shares the same ECP distribution channel.

Others

  • Heidelberg Engineering: Heidelberg Engineering specializes in diagnostic imaging for ophthalmology (Spectralis OCT, HRT). While not directly competitive with J&J Vision's products, it serves the same ECP customer base with complementary diagnostic equipment.

Emerging players

  • Glaukos Corporation: Glaukos is an emerging player in ophthalmic medical devices focused on MIGS (micro-invasive glaucoma surgery) and dry eye treatment (iDose TR). Adjacent to J&J Vision's ocular surface portfolio (LipiFlow) and represents a competitor in newer ophthalmic treatment modalities.
  • Topcon Healthcare: Topcon Healthcare provides ophthalmic diagnostic equipment, imaging systems, and healthcare IT solutions. Overlaps with J&J Vision's LipiScan/LipiView ocular surface diagnostics and competes for ECP practice equipment budgets.

Market position

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

johnson & johnson vision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

johnson & johnson vision leadership team

Management profile

Number of profiles

johnson & johnson vision funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

johnson & johnson vision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about johnson & johnson vision

What does johnson & johnson vision do?

Johnson & Johnson Vision manufactures and sells ACUVUE® brand contact lenses (daily disposable, two-week, and monthly modalities for spherical, toric/astigmatism, and multifocal/presbyopia correction), surgical vision products including TECNIS® intraocular lenses and the CATALYS® precision laser cataract surgery system, and ocular surface diagnostics and treatment systems (LipiFlow®, LipiScan®, LipiView®) for meibomian gland dysfunction. Products are sold primarily through a field sales force and direct ordering portal to eye care professionals, with a parallel consumer ecommerce channel.

Is johnson & johnson vision a public or private company?

johnson & johnson vision is a public company. It is classified as corporate owned and is currently operating.

When was johnson & johnson vision founded?

johnson & johnson vision was founded in 1950.

Where is johnson & johnson vision based?

johnson & johnson vision is headquartered in Jacksonville, United States, in the North America region.

How does johnson & johnson vision make money?

Four revenue lines are on record. Contact Lens Sales are the primary driver. The others are surgical Vision Products, ocular Surface Diagnostics and Treatment and practice Services and Programs.

Who are johnson & johnson vision's main competitors?

Direct peers on record are CooperVision, Bausch + Lomb, Carl Zeiss Meditec, HOYA Corporation, Alcon and STAAR Surgical. EssilorLuxottica is listed as a broad incumbent. Heidelberg Engineering is listed as an others. Emerging players are Glaukos Corporation and Topcon Healthcare.

Does johnson & johnson vision have an API?

No public API is recorded for johnson & johnson vision.

What industry is johnson & johnson vision in?

johnson & johnson vision's product category is Ophthalmic Medical Devices and Contact Lenses. Its primary akta.pro industry code is HLAHAJAE, Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions), with a secondary code of HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics). Its NAICS code is 339115 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooU.S. Physical Therapy Announces CFOU.S. Physical Therapy, Inc. announced that Nchacha Etta will serve as its Executive Vice President and Chief Financial Officer, effective September 1, 2026. Etta succeeds Jason Curtis, who served as interim CFO since April 2026 and will remain in his role as Senior Vice President of Finance and Accounting. Etta brings prior executive finance experience from companies including Omnicell, EssilorLuxottica, Johnson & Johnson Vision, The Coca-Cola Company, Microsoft, and Eli Lilly.Ophthalmology TimesSpotlight on dry eye: Create a process, offer packagesDr. Mitchell A. Jackson outlines a clinical strategy for managing dry eye disease by implementing customized diagnostic and treatment packages to improve patient outcomes and practice efficiency. The approach integrates objective diagnostic data with various therapeutic options, including device-based procedures from manufacturers like Alcon and Johnson & Johnson Vision, alongside prescription medications and nutritional supplements. This method aims to enhance patient adherence through education and streamline the management of ocular surface diseases within referral-based practices.Ophthalmology TimesPost-LASIK presbyopia: Meeting expectations with evolving technologyThe article outlines evolving medical technologies and surgical strategies for managing presbyopia in patients who previously underwent LASIK surgery. It highlights specific intraocular lens options, including Light Adjustable Lenses (RxSight), Extended Depth-of-Focus lenses (Johnson & Johnson Vision, Alcon), and monofocal plus lenses (Bausch + Lomb, Rayner), alongside AI-driven biometry tools to improve refractive accuracy. These advancements aim to address the unique optical challenges posed by prior corneal reshaping while managing patient expectations for visual outcomes.Ophthalmology TimesDepth-of-focus enhancement makes target easier to hitOphthalmologist Carlton Yuen reports using the Tecnis Eyhance IOL (ICB00), manufactured by Johnson & Johnson Vision, as a default lens for premium cataract surgery to improve distance vision accuracy and intermediate visual outcomes. Clinical observations indicate that the lens's extended depth of focus helps mask residual astigmatism and refractive errors, resulting in high-quality distance acuity (mean 20/25) in patients without other ocular pathology. The author expects this technology to replace standard monofocal lenses in approximately 40% of his cases due to its ability to broaden the surgical success zone.TalkMarketsSigns You May Need Cataract Eye SurgeryThe article provides a comprehensive guide on identifying symptoms of cataracts, such as blurry vision and night blindness, that indicate the need for surgical intervention. It details various surgical methods like phacoemulsification and laser-assisted procedures, along with cost estimates in India ranging from ₹20,000 to over ₹150,000 depending on the intraocular lens type. The text also lists major medical device manufacturers including Johnson & Johnson, Alcon, and Bausch + Lomb whose lenses are used in these procedures.Business Research InsightsIntraocular Lens Market Size, ShareThe global Intraocular Lens (IOL) Market is valued at USD 5.01 billion in 2026 and is projected to reach USD 9.41 billion by 2035, growing at a CAGR of 7.26%, driven by rising cataract prevalence, aging populations, and increasing demand for premium lenses. North America leads the market with 38% share, while the Asia-Pacific region shows the fastest growth due to expanding healthcare infrastructure and government blindness prevention programs. Key industry players including Alcon, Johnson & Johnson Vision, Bausch + Lomb, Carl Zeiss Meditec, and Hoya Corporation continue to drive innovation through advanced IOL technologies such as light-adjustable lenses and multifocal designs.AD HOC NEWSAcuvue contact lenses for clear, flexible vision in the USJohnson & Johnson markets the Acuvue brand of soft disposable contact lenses in the United States as a vision correction alternative to glasses. The product portfolio includes various replacement schedules and specialized designs for conditions such as astigmatism and presbyopia, with some models offering UV-blocking properties. Distribution occurs through licensed eye care professionals and retailers under FDA regulation.Market Research FutureIntraocular Lens Market Size, Share & Trends Report 2035A comprehensive market research report projects the global Intraocular Lens Market will grow from USD 5.03 billion in 2024 to USD 9.28 billion by 2035, representing a CAGR of 5.72%, driven by rising cataract prevalence, technological advancements in lens design, and an aging global population. North America dominated with over 50% market share in 2024, while the report identifies key players including Alcon, Johnson & Johnson, and Bausch + Lomb as primary market participants driving innovation and consolidation. Recent industry developments include Bausch + Lomb's acquisition of a competitor specializing in innovative lens technologies and Johnson & Johnson's strategic partnership in telemedicine for eye care.openPR.comOphthalmic Surgery Devices Market Is Booming Rapidly with Strong Demand By 2033 | Alcon, Johnson and Johnson Vision, Bausch and LombThe article discusses the booming ophthalmic surgery devices market, with key companies such as Alcon, Johnson and Johnson Vision, and Bausch and Lomb actively involved in the industry's growth. The market is segmented by product type and application, with regional analysis covering multiple global regions.EIN PresswireDr. Steven J. Dell of Dell Laser Consultants Among the First Surgeons in the U.S. to Implant the New TECNIS PureSee™ IOLDell Laser Consultants in Austin, Texas, announced it is among the first practices in the United States to offer the TECNIS PureSee™ intraocular lens (IOL), a new extended depth of focus (EDOF) lens manufactured by Johnson & Johnson Vision. The TECNIS PureSee™ IOL is the first and only FDA-approved EDOF IOL in the United States with no warning on loss of contrast sensitivity, and clinical trial data showed 97% of patients reported no very bothersome visual disturbances. Dr. Steven J. Dell's early access to the lens reflects his long-standing consulting relationships with leading ophthalmic companies and his history of bringing new technologies to patients ahead of most practices nationwide.